These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24932767)

  • 1. Boston keratoprosthesis type 1 for herpes simplex and herpes zoster keratopathy.
    Brown CR; Wagoner MD; Welder JD; Cohen AW; Goins KM; Greiner MA; Kitzmann AS
    Cornea; 2014 Aug; 33(8):801-5. PubMed ID: 24932767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Boston keratoprosthesis in herpetic keratitis.
    Khan BF; Harissi-Dagher M; Pavan-Langston D; Aquavella JV; Dohlman CH
    Arch Ophthalmol; 2007 Jun; 125(6):745-9. PubMed ID: 17562983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of the Boston type I keratoprosthesis in eyes with previous herpes simplex virus keratitis.
    Fry M; Aravena C; Yu F; Kattan J; Aldave AJ
    Br J Ophthalmol; 2018 Jan; 102(1):48-53. PubMed ID: 28495905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial Keratitis and Endophthalmitis After the Boston Type 1 Keratoprosthesis.
    Wagoner MD; Welder JD; Goins KM; Greiner MA
    Cornea; 2016 Apr; 35(4):486-93. PubMed ID: 26764885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boston type 1 keratoprosthesis for primary congenital glaucoma.
    Haugsdal JM; Goins KM; Greiner MA; Kwon YH; Alward WL; Wagoner MD
    Br J Ophthalmol; 2016 Mar; 100(3):328-31. PubMed ID: 26206789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boston type 1 keratoprosthesis for chemical and thermal injury.
    Phillips DL; Hager JL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
    Cornea; 2014 Sep; 33(9):905-9. PubMed ID: 25055151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.
    Wu SQ; Zhou P; Zhang B; Qiu WY; Yao YF
    Am J Ophthalmol; 2012 Feb; 153(2):291-299.e2. PubMed ID: 21996306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
    Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
    Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL; Belin MW; Ciolino JB;
    Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of aniridia with Boston type I keratoprosthesis.
    Rixen JJ; Cohen AW; Kitzmann AS; Wagoner MD; Goins KM
    Cornea; 2013 Jul; 32(7):947-50. PubMed ID: 23449480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C; Bozkurt TK; Yu F; Aldave AJ
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and management of patients with Boston type 1 keratoprosthesis explantation--the University of Montreal Hospital Center experience.
    Wang Q; Harissi-Dagher M
    Am J Ophthalmol; 2014 Dec; 158(6):1297-1304.e1. PubMed ID: 25174898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.